In a landmark decision, the European Commission fined Teva Pharmaceuticals 462.6 million euros for leveraging its dominant position to delay the market entry of competitor treatments for multiple sclerosis (MS). The fine addresses both Teva's manipulation of patent protections and its misleading marketing tactics,...
On 30 October 2024, the Rotterdam district court ruled to dismiss claims by the Stichting Petrobras Compensation Foundation against Petrobras, the Brazilian oil company. The Dutch foundation aimed to secure compensation on behalf of investors who traded Petrobras shares outside the U.S., asserting they...
